LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
2020 · Oncogenesis · 43 citations
https://doi.org/10.1038/s41389-020-00263-1
S
Suresh Chava
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
336
Citations
11
h-index
12
i10-index
Suresh Chava is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Histone Deacetylase Inhibitors Research & Cancer, Hypoxia, and Metabolism & Epigenetics and DNA Methylation. The author has an h-index of 11, co-authored 21 publications.
ORCID: 0000-0002-9360-5249Papers by this author
worksLoss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R
2020 · Oncogenesis · 27 citations
https://doi.org/10.1038/s41389-020-0228-x
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
2021 · Oncogenesis · 26 citations
https://doi.org/10.1038/s41389-021-00339-6
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B
2023 · Cell Reports Medicine · 20 citations
https://doi.org/10.1016/j.xcrm.2023.101285
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE
2023 · Cell Death and Disease · 14 citations
https://doi.org/10.1038/s41419-023-05993-9
Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis
2022 · iScience · 10 citations
https://doi.org/10.1016/j.isci.2022.104211
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat